Werkgroep Cardiologische centra Nederland English

AVANT GARDE (Klaar)

A randomized, double-blind, parallel-group, placebocontrolled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in stabilized patients post acute coronary syndromes
Middel
aliskiren
Populatie
ASCVD
Fase
II
Jaar aanvang
2006